Skip to content

Multiple endocrine neoplasia





Population genetics
Genetic disorders
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Hereditary spherocytosis
Huntington disease
Li-Fraumeni syndrome
Marfan syndrome
Multiple endocrine neoplasia
Myotonic dystrophy
Treacher Collins syndrome
Tuberous sclerosis
von Hippel-Lindau disease
Polycystic kidney disease
Cystic fibrosis
Friedreich ataxia
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Krabbe disease
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Primary ciliary dyskinesia
Phenylketonuria (NORD)
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Wilson disease
Fragile X syndrome
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Lesch-Nyhan syndrome
Muscular dystrophy
Ornithine transcarbamylase deficiency
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review

Multiple endocrine neoplasia


0 / 23 complete


0 / 3 complete
High Yield Notes
13 pages

Multiple endocrine neoplasia

23 flashcards

USMLE® Step 1 style questions USMLE

3 questions

A 48-year-old woman comes to the clinic complaining of episodic headaches and sweating for the past several months. Several times a week, the patient feels the sudden onset of a diffuse frontal headache associated with heart palpitations and whole-body sweating, lasting for at least twenty minutes. The patient does not drink caffeine or alcohol or use illicit drugs. Medical history includes hypertension, for which she takes nifedipine and carvedilol. The patient’s father was diagnosed with multiple endocrine neoplasia type 2A in adulthood. The patient’s temperature is 37.0°C (98.6°F), pulse is 80/min, respirations are 20/min, and blood pressure is 150/90 mmHg. Physical examination shows a well-appearing female in no apparent distress. Which of the following findings is most likely to be present in this patient?  

External References

The multiple endocrine neoplasias, or MEN for short, are a group of inherited diseases which cause tumors to grow in the endocrine glands of the body.

The endocrine glands affected in multiple endocrine neoplasia are the pituitary gland, the thyroid gland, the parathyroid glands, the adrenal glands and the pancreas.

So in multiple endocrine neoplasias there are tumors that form in these glands that lead to overproduction of hormones.

Let’s start by going through the glands that are affected and what they do.

The pituitary gland is a pea-sized gland found at the base of the brain that makes hormones to control many of the other endocrine glands in the body.

These hormones include thyroid stimulating hormone which acts on the thyroid to make thyroid hormone, adrenal corticotropic hormone that acts on the adrenal glands to make cortisol, follicle stimulating hormone and luteinizing hormone which acts on the ovaries and testes to make estrogen in women and testosterone in men.

So it’s like the king of the endocrine glands telling them how much hormone to produce.

The pituitary also makes growth hormone which makes you grow, prolactin which stimulates milk production in women, oxytocin which triggers milk release, antidiuretic hormone which help the kidneys reabsorb water, and melanocyte stimulating hormone helps the melanocytes create more melanin or pigment.

Next, in the neck is the thyroid gland which makes thyroid hormones that control the metabolic rate, as well as calcitonin, a hormone that decreases calcium levels.

Within the thyroid gland, are buried four parathyroid glands which make parathyroid hormone which increases calcium levels.

Lower down, there are the adrenal glands which sit just above each kidney and produce epinephrine and norepinephrine which are fight or flight hormones that increase cardiac output, dilate the pupils, and increase blood flow to the muscles.

Finally, there’s the pancreas which makes insulin to help lower blood sugar, and glucagon to help raise blood sugar.

The pancreas also makes gastrin which increases hydrochloric acid production in the stomach, and vasoactive intestinal peptide which relaxes the intestinal wall allowing food to pass.

Multiple endocrine neoplasias are caused by genetic mutations to one of two genes, either MEN1 or RET.

Both of these genes have a dominant inheritance pattern, so you only need one copy of the mutated gene to get the disease.

The MEN1 gene is found on chromosome 11 and is a tumor suppressor gene, meaning it normally stops a cell from dividing uncontrollably.

An MEN1 mutation causes MEN type 1.

On the other hand, RET is a proto oncogene which promotes normal cell division, and when it mutates, it becomes an oncogene which promotes constant cell division.

Mutated RET causes multiple endocrine neoplasia type 2A and 2B.

In multiple endocrine neoplasia type 1, there are three types of tumors: parathyroid, pancreatic, and pituitary.

The most common tumor is a parathyroid tumor.

Increased parathyroid hormone causes increased bone breakdown which leads to hypercalcemia and calcium kidney stones.

Pancreatic tumors cause problems based on the type of hormone they produce.


Multiple endocrine neoplasias, or MEN for short, are a group of inherited diseases that cause tumors to grow in the endocrine glands of the body. MEN tumors are classified into two broad categories based on their underlying mutations. There is MEN1 caused by a mutation in the MEN1 gene, and MEN2, which is caused by a mutation in the RET gene.

People with MEN1 present with tumors in the pituitary gland or parathyroid glands and pancreatic tumors. MEN2 is further divided into two subtypes: MEN2A and MEN2B. MEN2A is characterized by medullary thyroid cancer, pheochromocytoma, and parathyroid tumors; whereas MEN2B presents with medullary thyroid cancer, pheochromocytoma, and mucosal neuromas.

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Multiple endocrine neoplasia type 2: An overview" Genetics in Medicine (2011)
  6. "Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1)" Experimental and Clinical Endocrinology & Diabetes (2000)
  7. "Multiple endocrine neoplasia type 2: An overview" Genetics in Medicine (2011)